Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|January 1, 2015
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trialAlf Kastbom, Kristina Forslind, Sofia Ernestam, et al.
RMD Open|March 10, 2016
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trialKaren Hambardzumyan, Rebecca J Bolce, Saedis Saevarsdottir, et al.
Frontiers in Immunology|August 15, 2020
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases EarlierNastya Kharlamova, Christina Hermanrud, Nicky Dunn, et al.
Annals of the Rheumatic Diseases|May 10, 2014
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trialKaren Hambardzumyan, Rebecca Bolce, Saedis Saevarsdottir, et al.
RMD Open|September 6, 2023
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohortsHelga Westerlind, Bente Glintborg, Hilde Berner Hammer, et al.
Arthritis and Rheumatism|February 7, 2012
Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritisJudit Laki, Emeli Lundström, Omri Snir, et al.
RMD Open|July 9, 2026
Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritisAxel Finckh, Delphine S Courvoisier, Romain Aymon, et al.
Rheumatology (Oxford, England)|November 14, 2019
An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databasesAntoine Vanier, Josef S Smolen, Cornelia F Allaart, et al.
Current Medical Research and Opinion|February 20, 2019
Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studiesJeffrey R Curtis, Cecilie H Brahe, Mikkel Østergaard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2015
Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterionRonald F van Vollenhoven, Rebecca Bolce, Karen Hambardzumyan, et al.
Pageof 11